Perrigo Co (BSP:P1RG34) Total Liabilities : R$29,646 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Total Liabilities?

Perrigo Co's Total Liabilities for the quarter that ended in Mar. 2024 was R$29,646 Mil.

Perrigo Co's quarterly Total Liabilities declined from Sep. 2023 (R$29,731.96 Mil) to Dec. 2023 (R$29,600.67 Mil) but then increased from Dec. 2023 (R$29,600.67 Mil) to Mar. 2024 (R$29,646.24 Mil).

Perrigo Co's annual Total Liabilities increased from Dec. 2021 (R$29,823.94 Mil) to Dec. 2022 (R$32,391.39 Mil) but then declined from Dec. 2022 (R$32,391.39 Mil) to Dec. 2023 (R$29,600.67 Mil).

Perrigo Co Total Liabilities Historical Data

The historical data trend for Perrigo Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Total Liabilities Chart

Perrigo Co Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

22,563.67

30,010.58

29,823.94

32,391.39

29,600.67

Perrigo Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															31,881.84	29,685.72	29,731.96	29,600.67	29,646.24

Perrigo Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Perrigo Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7772.553	+	(17799.993	+	2742.908
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	1285.218	+	0)
	=	29,601

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	52962.428	-	23361.756
	=	29,601

Perrigo Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7741.099	+	(18051.277	+	2620.371
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	1233.496	+	0)
	=	29,646

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	52986.566	-	23340.323
	=	29,646

Perrigo Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Perrigo Co (BSP:P1RG34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

PRGO:USA PIG:Germany

Address

The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74

Website

https://www.perrigo.com

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (BSP:P1RG34) Headlines

No Headlines